Therapeutics
Engineering Cells For Cures
ST PHI THERAPEUTICS OVERVIEW
Advancing the Next Generation of Innovative Cell Therapy For Cancer, Infection and Autoimmune Diseases
CNK-UT THERAPY
addressing unmet clinical needs with significant market potential
ADVANTAGE
A unique and versatile platform for tumor, both T cells and B cells mediated autoimmune diseases
OFF-THE-SHELF
Universal“off-the-shelf” cell therapy
ENDORSEMENT
Encouraging clinical results from pilot studies
EXCELLENT TEAM
Led by world-class immunotherapy experts
R&D AND PRODUCTION
R&D Platform
Proprietary CNK-UT Technology Overview
Our CNK-UT enables multi-targeting and specific potent cytotoxicity against tumor cells-superior to general NK and CAR-T cells
Manufacturing
Established GMP Allogeneic CAR-T cells Manufacturing Facility for High Yields, Low Cost and Broad Clinical Application
An industrial scale manufacturing facility in Hangzhou, China is established and approved by NMPA for Phase I trials
PIPELINE
Mission and Vision
Engineering Cells For Cures